Portfolio company Bambusa Therapeutics presented at the 44th Annual J.P. Morgan Healthcare Conference.
Bambusa Therapeutics is a biotechnology company developing bispecific antibodies for immunological and inflammatory disorders, aiming to transform patient outcomes and enhance quality of life
Bambusa Therapeutics is a biotechnology company developing bispecific antibodies for immunological and inflammatory disorders, aiming to transform patient outcomes and enhance quality of life.